# Tyra Biosciences, Inc.: Form SCHEDULE 13D/A, filed Mar 6, 2026

- Company: [Tyra Biosciences, Inc.](/companies/tyra.md) (CIK 1863127)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-06
- Accepted by EDGAR: Mar 6, 2026, 16:28 ET
- Period: not reported
- Accession: 0001346824-26-000068
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1863127/000134682426000068/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1863127/000134682426000068/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1863127/000134682426000068/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001346824-26-000068. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
